vs
Side-by-side financial comparison of BingEx Ltd (FLX) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
BingEx Ltd is the larger business by last-quarter revenue ($143.2M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). BingEx Ltd runs the higher net margin — 2.2% vs -38.1%, a 40.3% gap on every dollar of revenue.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
FLX vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $143.2M | $83.1M |
| Net Profit | $3.2M | $-31.6M |
| Gross Margin | 10.8% | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 2.2% | -38.1% |
| Revenue YoY | — | 20.2% |
| Net Profit YoY | — | -27.9% |
| EPS (diluted) | — | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $143.2M | $83.1M | ||
| Q4 25 | — | $76.4M | ||
| Q3 25 | $141.2M | $83.3M | ||
| Q2 25 | $143.0M | $79.2M | ||
| Q1 25 | $141.0M | $69.2M | ||
| Q4 24 | — | $68.2M | ||
| Q3 24 | $164.6M | $58.4M | ||
| Q2 24 | — | $53.4M |
| Q1 26 | $3.2M | $-31.6M | ||
| Q4 25 | — | $-29.8M | ||
| Q3 25 | $6.1M | $-21.4M | ||
| Q2 25 | $7.5M | $-19.6M | ||
| Q1 25 | $27.6M | $-24.7M | ||
| Q4 24 | — | $-18.9M | ||
| Q3 24 | $3.4M | $-21.0M | ||
| Q2 24 | — | $-25.6M |
| Q1 26 | 10.8% | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | 11.1% | 64.8% | ||
| Q2 25 | 12.0% | 65.4% | ||
| Q1 25 | 10.0% | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | 11.3% | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | 1.4% | -27.8% | ||
| Q2 25 | 1.9% | -28.0% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | 4.0% | -38.4% | ||
| Q2 24 | — | -50.3% |
| Q1 26 | 2.2% | -38.1% | ||
| Q4 25 | — | -39.1% | ||
| Q3 25 | 4.4% | -25.7% | ||
| Q2 25 | 5.2% | -24.7% | ||
| Q1 25 | 19.6% | -35.8% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | 2.1% | -35.9% | ||
| Q2 24 | — | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | — | $-0.54 | ||
| Q3 25 | — | $-0.38 | ||
| Q2 25 | — | $-0.35 | ||
| Q1 25 | — | $-0.45 | ||
| Q4 24 | — | $-0.34 | ||
| Q3 24 | — | $-0.40 | ||
| Q2 24 | — | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $561.1M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | — | $347.7M |
| Total Assets | $1.3B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $561.1M | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | $628.6M | $294.3M | ||
| Q2 25 | $499.4M | $302.7M | ||
| Q1 25 | $592.4M | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | $517.4M | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | — | $365.9M | ||
| Q3 25 | — | $380.3M | ||
| Q2 25 | — | $385.8M | ||
| Q1 25 | — | $389.2M | ||
| Q4 24 | — | $402.2M | ||
| Q3 24 | — | $241.2M | ||
| Q2 24 | — | $251.8M |
| Q1 26 | $1.3B | $487.1M | ||
| Q4 25 | — | $508.1M | ||
| Q3 25 | $1.3B | $511.5M | ||
| Q2 25 | $1.2B | $513.1M | ||
| Q1 25 | $1.2B | $519.4M | ||
| Q4 24 | — | $534.0M | ||
| Q3 24 | $926.8M | $374.1M | ||
| Q2 24 | — | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FLX
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
